| Primary Myelofibrosis studied in …STUDIED_INderived200 of 242show all (up to 200) |
|---|
| → studied in | NCT03560752Phase 1 · active not recruiting CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025488Phase 1 · active not recruiting Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06398457early Phase 1 · recruiting Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320198Phase 1/Phase 2 · recruiting Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530034Phase 1 · active not recruiting Hu8F4 in Treating Patients With Advanced Hematologic Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469891Phase 1 · recruiting A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06397313Phase 2 · terminated RVU120 in Patients With Intermediate or High-risk, Primary or Secondary Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831635completed Myeloproliferative Neoplasms: an In-depth Case-control Study · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05875805NA · recruiting A Telehealth Advance Care Planning Intervention · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07805746not yet recruiting Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661915Phase 2 · recruiting A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02386800Phase 4 · active not recruiting CINC424A2X01B Rollover Protocol · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228624Phase 2 · recruiting Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001385Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302776Phase 1 · recruiting TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06468033Phase 3 · active not recruiting P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361641NA · recruiting Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506933Phase 2 · active not recruiting Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020533Phase 1 · recruiting A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07250646Phase 1 · recruiting A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03480360Phase 3 · completed Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Overt Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04717414Phase 3 · active not recruiting An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05233618Phase 1 · active not recruiting Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128381Phase 1/Phase 2 · recruiting Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04328844Phase 1 · active not recruiting A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576156Phase 3 · active not recruiting A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04217356active not recruiting Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805605Phase 2 · recruiting Allo HSCT Using RIC and PTCy for Hematological Diseases · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03314974Phase 2 · recruiting Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289910Phase 2 · active not recruiting Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081874Phase 1/Phase 2 · completed RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03441113Phase 2 · active not recruiting Extended Access of Momelotinib in Adults With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04517851Phase 2 · active not recruiting Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02158858Phase 1/Phase 2 · completed A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964506early Phase 1 · recruiting Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05364762Phase 2 · active not recruiting Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07379125Phase 1 · recruiting Therapeutic RSK1 Targeting in Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01962636NA · terminated Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02493530Phase 1 · completed TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07590986recruiting Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04817007Phase 1/Phase 2 · active not recruiting A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05467800Phase 2 · active not recruiting Study of Canakinumab in Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05835466Phase 2 · recruiting Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771572Phase 1 · recruiting Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04888741Phase 2 · recruiting Methods of T Cell Depletion Trial (MoTD) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878199Phase 1/Phase 2 · terminated Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07539779Phase 2/Phase 3 · not yet recruiting Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529951Phase 1 · not yet recruiting Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047886Phase 1 · recruiting UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562389Phase 3 · active not recruiting Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518940NA · not yet recruiting ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05972577NA · completed Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351631Phase 3 · recruiting A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04279847Phase 1 · active not recruiting Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787487Phase 2 · completed Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339101Phase 2 · completed Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063486Phase 2 · recruiting Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04472598Phase 3 · completed Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198960Phase 3 · recruiting AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Prefibrotic Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06859424Phase 2 · recruiting A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123365Phase 1/Phase 2 · recruiting An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06059391Phase 2 · recruiting CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758042NA · completed Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04942080NA · recruiting Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Prefibrotic Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07215832available Karyopharm Expanded Access Program for Selinexor · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07419178NA · recruiting A New Diagnostic Algorithm to Non-invasively Track Fibrotic Changes in Myeloproliferative Neoplasms Based on C-C Chemokine Receptor 2 Detection. From Flow Cytometry to the Development of Targeted Positron Emission Tomography Molecular Imaging. Pre-clinical Studies and First In-human Proof of Concept · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455294Phase 1 · active not recruiting Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04468984Phase 3 · active not recruiting Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03912064Phase 1 · active not recruiting A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255346Phase 2 · completed Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03326310Phase 1 · recruiting Selumetinib and Azacitidine in High Risk Chronic Blood Cancers · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541249Phase 2 · recruiting MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745637available Managed Access Programs for INC424, Ruxolitinib · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04060277Phase 2 · active not recruiting Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760655Phase 2 · completed Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03452774recruiting SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551066Phase 3 · terminated To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06712810Phase 1 · recruiting Q702 for the Treatment of Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551053Phase 3 · terminated To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223920Phase 2 · completed An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005) · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04629508Phase 2 · completed To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03952039Phase 3 · completed An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermediate or High-risk Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, or Post-essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378437Phase 1 · recruiting A Study of GLB-001 in Patients With Myeloid Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04454658Phase 1 · active not recruiting Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333486Phase 2 · terminated Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688011terminated Connect® Myeloid Disease Registry · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01290302Phase 1 · completed Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923670NA · not yet recruiting Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05423691Phase 1 · recruiting Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00719888Phase 2 · completed Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02396134Phase 2 · completed Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04281498Phase 2 · completed Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation · condition mapped PROBABILISTIC · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798805active not recruiting Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05488548Phase 1 · recruiting Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02268253Phase 1/Phase 2 · completed Tagraxofusp (SL-401) in Participants With Chronic Myelomonocytic Leukemia (CMML) and Myelofibrosis (MF) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03869476NA · completed Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Prefibrotic Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755518Phase 3 · terminated A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760238recruiting Myeloproliferative Neoplasms (MPNs) Patient Registry · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897297unknown Myeloproliferative Neoplastic Diseases Observatory From Brest · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00522990Phase 1/Phase 2 · terminated Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04243122Phase 2 · completed Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655118Phase 2 · unknown Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03592576no longer available Expanded Access to Navitoclax · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218628Phase 1 · recruiting Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06371573completed Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666025completed SARS-CoV-2 Donor-Recipient Immunity Transfer · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05444972completed A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02916979Phase 1 · completed Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04629651Phase 1/Phase 2 · withdrawn Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01712308Phase 2 · completed Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01428635Phase 2/Phase 3 · completed Eltrombopag Olamine in Treating Thrombocytopenia in Patients With Chronic Myeloid Leukemia or Myelofibrosis Receiving Tyrosine Kinase Therapy · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04480086Phase 1 · terminated Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03194542Phase 2 · completed A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816256NA · completed Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03566446Phase 1 · completed CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02124746Phase 2 · completed Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04896112Phase 1 · withdrawn A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02440685Phase 1/Phase 2 · terminated A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02098161Phase 2 · completed LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05882773recruiting Asian Myeloproliferative Neoplasm (MPN) Registry · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02581007Phase 2 · completed Reduced Intensity Conditioning Transplant Using Haploidentical Donors · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354120Phase 2/Phase 3 · completed Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03895112Phase 1 · completed MPN-RC 118 AVID200 in Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04153305completed European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04629430NA · completed Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04866056Phase 1/Phase 2 · terminated Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF. · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02556931Phase 2 · completed Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02065154Phase 2 · completed Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03645824Phase 2 · active not recruiting Myelofibrosis Treated With Pacritinib Before aSCT. (HOVON134MF) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014546Phase 1 · terminated Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04354727Phase 1/Phase 2 · withdrawn A Study of APG-1252 in Patients With Myelofibrosis Who Progressed After Initial Therapy · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03303950Phase 2 · terminated Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04709458Phase 1 · unknown Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01423851Phase 1/Phase 2 · completed Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01981850Phase 2 · completed A Phase 2 Study of RO7490677 In Participants With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02055781Phase 3 · terminated Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02660281Phase 1 · completed URMC Related Haplo-identical Donor BMT · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04464889Phase 1 · withdrawn HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01731951Phase 2 · completed Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03018223Phase 1 · completed Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01814475Phase 2 · completed Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602898Phase 2 · withdrawn Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03065400Phase 2 · completed PD-1 Inhibition in Advanced Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530619NA · unknown Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129582Phase 1 · completed Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04283526Phase 1 · withdrawn Study of Select Combinations in Adults With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00489203Phase 2 · completed Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01300611Phase 1 · terminated TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02181478early Phase 1 · completed Intra-Osseous Co-Transplant of UCB and hMSC · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01773187Phase 3 · terminated Pacritinib Versus Best Available Therapy to Treat Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00309842Phase 2 · completed Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121599NA · terminated 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Overt Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02730884Phase 2 · terminated Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01369498Phase 2 · completed Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03718143Phase 2 · terminated AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787552Phase 1/Phase 2 · completed A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907436NA · completed The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02435550NA · terminated iCare for Cancer Patients · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03745378completed Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study) · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00463385Phase 2 · completed A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00856388NA · completed Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129101Phase 1 · completed Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03195010Phase 2 · terminated Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715247completed Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02167958Phase 1 · completed Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00997386Phase 2 · completed Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02871323Phase 1 · withdrawn Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04054245Phase 2 · withdrawn PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01417520completed Clinical and Pathophysiological Investigations Into Erdheim Chester Disease · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01178281Phase 3 · completed Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666549completed Research Tissue Bank · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01159067Phase 2 · terminated Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00475020Phase 2 · completed Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311569Phase 2 · completed Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02421354Phase 2 · terminated Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665067completed Correlative Biomarker Study in Patients With Myeloproliferative Disorders · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03438344Phase 2 · withdrawn Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01499147NA · completed Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728700Phase 1 · terminated Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01273766Phase 2 · completed Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01484015Phase 1 · completed Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02877082Phase 2 · terminated Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134120Phase 1 · completed A Study in Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509899Phase 1/Phase 2 · completed Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00852709Phase 1 · terminated Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666289completed Familial Myeloproliferative Disorders · condition mapped ALIAS · 242 trials mapped (75 active) | — | — | Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |